Amgen Inc. (AMGN) — Stock Score Summary

Amgen Inc. (AMGN) has a MoatMap StockRank of 88/100 based on Quality (67/100), Value (40/100), and Momentum (66/100) factor scores. The current signal is STRONG BUY. Amgen is a high-quality global biotech giant with stable cash flows. However, it lacks a high-velocity macro tailwind over the next 18 months, and its large scale makes finding high-ROIC reinvestment runways increasingly challenging compared to nimbler players.

Amgen Inc. is a leading global biotechnology company dedicated to discovering, developing, and manufacturing innovative human therapeutics across oncology, cardiovascular disease, and bone health. The company's competitive moat is built upon its extensive pipeline of biologics, strong intellectual property protection for blockbuster drugs, and significant R&D investment, positioning it as a pioneer in biotechnology leveraging scientific expertise.

Key Financial Metrics

Price$346.58
Market Cap$181.6B
P/E (TTM)24.03
P/E (Forward)14.72
Price/Book20.30
Return on Equity101.3%
Return on Invested Capital18.0%
Debt/Equity623.75
Gross Margin71.4%
Operating Margin33.8%
Revenue Growth5.8%
Dividend Yield2.9%
Free Cash Flow$7.4B

Amgen Inc. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Amgen Inc.’s (AMGN) StockRank?
MoatMap’s StockRank for Amgen Inc. (AMGN) is 88/100, with a Strong Buy signal. It is a composite of Quality (67), Value (40), and Momentum (66) factor ranks across MoatMap’s 19,000+ stock universe.
Does Amgen Inc. have an economic moat?
Amgen Inc. (AMGN) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Amgen Inc. a buy, hold, or sell?
MoatMap’s current signal for Amgen Inc. (AMGN) is Strong Buy, based on a StockRank of 88/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Amgen Inc. in?
Amgen Inc. (AMGN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (United States).
Browse all ranked stocksAMGN deep dive reportAI ChampionsHow we score stocksSense-check another stock